Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dezocine prophylaxis for remifentanil-induced cough during general anesthesia induction
ChiCTR2000032035Phase 4Not yet recruiting
- Sponsor
- International Peace Maternity and Child Health Hospital
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dezocine in cough (2 arms), sponsored by International Peace Maternity and Child Health Hospital. Primary endpoints: Remifentanil-induced cough occurrence, Heart rate and 2 more. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
dezocine
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR2000032035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032035.